Morten Madsen

Aarhus University

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

alma b pedersen

Aarhus University

DENMARK

View details

Pia Kjær Kristensen

Aarhus University

DENMARK

View details

Michael Maeng

Aarhus University Hospital

DENMARK

View details

Esben Søndergaard

Aarhus University Hospital

DENMARK

View details

Thomas Skaarup Godsk Jensen

Aarhus University

DENMARK

View details

Per Løgstrup Poulsen

Clinical Professor

Aarhus Universitet Health

DENMARK

View details

Kirstine Stochholm

Aarhus University Hospital

DENMARK

View details

Sebastian Kufner

GERMANY

View details

J J Coughlan

Ludwig-Maximilians-Universität München

GERMANY

View details

Lisette Okkels Jensen

DENMARK

View details

Cristina Rebordosa

Health Solutions

UNITED STATES

View details

Jeppe Vesterager

Aarhus University

DENMARK

View details

Jens Otto Lunde Jørgensen

Aarhus University Hospital

DENMARK

View details

Thomas Johannesson Hjelholt

Aarhus University

DENMARK

View details

Kevin Kris Warnakula Olesen

Aarhus University

DENMARK

View details

Andreas Ebbehøj

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Morten Madsen

Research Interests

Contact this professor

Articles (11)

Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes

Current Trends in Comorbidity Prevalence and Associated Mortality in a Population-Based Cohort of Hip Fracture Patients in Denmark

Association of anticholinergic drug use with postoperative mortality among patients with hip fracture. A nationwide cohort study

Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents

Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation

The socio-economic consequences of Cushing's syndrome

CHA2 DS2 -VASc impact on risk following percutaneous coronary intervention in atrial fibrillation

Comorbidity and Quality of In-Hospital Care for Hip Fracture Patients

Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention

Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018

Collaborators (16)

alma b pedersen

Pia Kjær Kristensen

Michael Maeng

Esben Søndergaard

Thomas Skaarup Godsk Jensen

Per Løgstrup Poulsen

Kirstine Stochholm

Sebastian Kufner

J J Coughlan

Lisette Okkels Jensen

Cristina Rebordosa

Jeppe Vesterager

Jens Otto Lunde Jørgensen

Thomas Johannesson Hjelholt

Kevin Kris Warnakula Olesen

Andreas Ebbehøj

Make your next move.